ENTITY
CanSino Biologics

CanSino Biologics (688185 CH)

90
Analysis
Health CareChina
CanSino Biologics Inc. develops and manufactures biological vaccine products. The Company discovers quadrivalence meningococcal conjugate, pneumococcal polysaccharide, and adenovirus vector-based tuberculosis vaccines for human use. CanSino Biologics serves customers worldwide.
more
Refresh
12 Jan 2023 11:01Syndicated

CX Daily: Why Countries Are Putting Curbs On Travelers From China

Caixin Explains: Why countries are putting curbs on travelers from China. Henan village banks start reimbursing large depositors

Logo
497 Views
Share
06 Sep 2022 09:45Syndicated

CX Daily: China’s Steel Industry at a Crossroads as Long Winter Looms

Cover Story: China’s steel industry at a crossroads as long winter looms. 33 cities in China are under some sort of lockdown

Logo
238 Views
Share
31 Aug 2022 09:57Syndicated

CX Daily: Washington’s Drive to Hobble Chinese Chipmaking

Caixin Explains: Washington’s drive to hobble Chinese chipmaking. Communist Party’s 20th National Congress to kick off on Oct. 16

Logo
164 Views
Share
07 Apr 2022 10:32Syndicated

CX Daily: China Turns to Credit Easing to Kick-Start Sluggish Economy

In Depth: China turns to credit easing to kick-start sluggish economy. Shanghai reverses Covid separation policy to let families stay with their...

Logo
186 Views
Share
x